Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 16, 2026
VIXY vs VXX: Two Specialized Vehicles for Short-Term Volatility Exposure

VIXY vs VXX: Two Specialized Vehicles for Short-Term Volatility Exposure

Key Takeaways

  • Both VIXY and VXX provide exposure to short-term VIX futures, targeting increases in expected S&P 500 volatility rather than equity ownership.
  • VIXY is structured as an ETF (commodity pool), while VXX is an ETN (exchange-traded note), introducing counterparty credit risk for the latter.
  • Expense ratios are competitive, with VIXY at 0.85% and VXX at 0.89%, reflecting the operational costs of futures roll strategies.
  • Neither ETF holds traditional equities or bonds; both maintain positions in near-term VIX futures contracts, leading to similar volatility sensitivity but potential differences in tracking and liquidity profiles.
  • These products serve as tactical tools for volatility hedging or speculation, with performance driven by futures curve dynamics such as contango rather than underlying company fundamentals.
  • Structural distinctions in legal form and issuer may influence long-term suitability depending on investor risk tolerance and platform considerations.

Introduction

ProShares VIX Short-Term Futures ETF (VIXY) and iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) represent specialized vehicles for accessing equity market volatility. They do not compete as core equity holdings but offer alternative strategies for investors seeking to hedge against or capitalize on spikes in the CBOE Volatility Index (VIX). In the current market environment characterized by shifting macroeconomic conditions and periodic uncertainty, these ETFs provide distinct yet closely aligned pathways to short-term volatility exposure.

A Closer Look at VIXY

ProShares VIX Short-Term Futures ETF (VIXY) seeks investment results that correspond to the performance of the S&P 500 VIX Short-Term Futures Index before fees and expenses. The fund employs a futures-based strategy with no traditional equity or fixed-income holdings; positions consist of near-term VIX futures contracts. It operates as an ETF structured as a commodity pool. The expense ratio stands at 0.85%. Distinguishing features include daily rebalancing of futures positions to maintain targeted exposure and options availability for enhanced trading flexibility. When I reviewed comparable instruments recently, I also checked this using Tickeron’s AI Screener to see how the fund aligns with other volatility products.

A Closer Look at VXX

iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX) is designed to deliver returns linked to the S&P 500 VIX Short-Term Futures Index Total Return. Like its counterpart, it relies on short-term VIX futures without conventional portfolio holdings. The product is structured as an ETN, a senior unsecured debt obligation of the issuer. The expense ratio is 0.89%. Key characteristics include passive tracking of the volatility futures index with periodic rolls of expiring contracts and listing on major U.S. exchanges for liquidity.

Industry and Thematic Context

Both ETFs operate within the volatility trading and hedging segment of the broader derivatives and alternative investment landscape. Macroeconomic drivers such as interest rate policy shifts, geopolitical tensions, and economic data releases influence demand for volatility products. Regulatory oversight from bodies like the U.S. Securities and Exchange Commission (SEC) governs ETN structures, emphasizing issuer creditworthiness. Capital flows into these instruments often rise during periods of market stress, while contango in the VIX futures curve poses a structural headwind through negative roll yields over extended holding periods.

Performance and Positioning

In recent market cycles, both VIXY and VXX have exhibited high sensitivity to volatility spikes driven by sector rotations, earnings announcements, and macroeconomic surprises. Their futures-based construction leads to comparable responses to short-term VIX movements, though differences in expense ratios and structure may contribute to minor tracking variations. Relative positioning favors tactical deployment during elevated uncertainty, with performance influenced by the shape of the futures curve rather than traditional sector allocations.

Enhancing Research with AI Tools

In my own analysis workflow, I often rely on Tickeron’s AI-powered tools to cross-reference data points and identify comparable instruments more efficiently. Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening.

My Assessment

Based on structural efficiency, slightly lower expense ratio, and ETF format without ETN counterparty considerations, Tickeron’s AI would currently assign a modest probabilistic preference to ProShares VIX Short-Term Futures ETF (VIXY) for investors prioritizing cost and legal structure within this volatility niche, while acknowledging that both instruments share highly similar exposure profiles.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VIXY, VXX

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


VIXY in +1.23% Uptrend, rising for three consecutive days on August 18, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where VIXY advanced for three days, in of 192 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for VIXY's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 14 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 31, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VIXY as a result. In of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for VIXY turned negative on August 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIXY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VIXY broke above its upper Bollinger Band on July 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for VIXY entered a downward trend on July 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Industry description

The investment seeks investment results, before fees and expenses, that over time, match the performance of the S&P 500 VIX Short-Term Futures Index for a single day. The index seeks to offer exposure to market volatility through publicly traded futures markets and is designed to measure the implied volatility of the S&P 500 over 30 days in the future.
View a ticker or compare two or three
VIXY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Miscellaneous
Address
ProShares Trust II7501 WISCONSIN AVEBethesda
Phone
240-497-6400
Web
www.proshares.com
Interact to see
Advertisement
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Intercontinental Exchange (ICE) has navigated recent market volatility while remaining within its 52-week range. Broader weakness in financial data and exchange operators has created short-term pressure, but ICE’s diversified business model continues to provide stability.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.